
m-PEG9-SH
CAS No. 651042-84-1
m-PEG9-SH( —— )
Catalog No. M26979 CAS No. 651042-84-1
m-PEG9-SH is a PEG-based PROTAC linker that can be used in the synthesis of PROTAC.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 42 | Get Quote |
![]() ![]() |
10MG | 59 | Get Quote |
![]() ![]() |
25MG | 95 | Get Quote |
![]() ![]() |
50MG | 138 | Get Quote |
![]() ![]() |
100MG | 201 | Get Quote |
![]() ![]() |
200MG | 287 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product Namem-PEG9-SH
-
NoteResearch use only, not for human use.
-
Brief Descriptionm-PEG9-SH is a PEG-based PROTAC linker that can be used in the synthesis of PROTAC.
-
Descriptionm-PEG9-SH is a PEG-based PROTAC linker that can be used in the synthesis of PROTAC.
-
In VitroPROTACs contain two different ligands connected by a linker; one is a ligand for an E3 ubiquitin ligase and the other is for the target protein. PROTACs exploit the intracellular ubiquitin-proteasome system to selectively degrade target proteins.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptorproporphyrinogen oxidase (PPO)
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number651042-84-1
-
Formula Weight444.58
-
Molecular FormulaC19H40O9S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOCCOCCOCCOCCOCCOCCOCCOCCOCCS
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Khorram MS, et al. Reduced mobility of fomesafen through enhanced adsorption in biochar-amended soil. Environ Toxicol Chem. 2015 Jun;34(6):1258-66.
molnova catalog



related products
-
Ethyl 5-methylhex-5-...
Ethyl 5-methylhex-5-enoate can be prepared from ethyl acrylate and isobutylene.
-
ML359
ML359 is a protein disulfide isomerase inhibitor.
-
Levovirin
Levovirin (L-Ribavirin), the L-enantiomer of ribavirin, is a guanosine nucleoside analog with immunomodulatory activity and is used in the study of hepatitis C virus infection.